CorneaGen
PrivateLast Round
Series B
Oct 7, 2019
Total Funding Raised
$47M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CorneaGen operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Series B round in October 2019.
CorneaGen is a medical device and biotechnology company that provides corneal transplant tissue, surgical instruments, and innovative therapeutic solutions to improve outcomes for patients with ocular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorneaGen Comparables
Compare CorneaGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brightstar Therapeutics | 80% | |
| Eversight | 76% | |
| KeraNatural | 76% |
For institutional investors. Book with your work email.
CorneaGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 7, 2019 | ||||
| Series A | Oct 18, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CorneaGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Petrichor Healthcare Capital Management | Series B |
| Flying L Partners | Series A, Series B |
| Falcon Vision | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 33% MoM, reaching 6.3K.
- Oct 7, 2019
$37M round led by Petrichor Healthcare Capital Management and Flying L Partners.
For institutional investors. Book with your work email.
CorneaGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CorneaGen's valuation, stock price, and market status.
Is CorneaGen a public or private company?
CorneaGen is a private company.
What is the current stock price of CorneaGen?
CorneaGen is a private company, so its shares have no public market price. Caplight tracks CorneaGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CorneaGen worth (valuation)?
Valuation information for CorneaGen is not publicly available.
Can I buy CorneaGen stock?
CorneaGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CorneaGen's last funding round?
CorneaGen's most recent funding round was Series B on October 7, 2019.
Who are the main investors in CorneaGen?
Key investors in CorneaGen include Petrichor Healthcare Capital Management, Flying L Partners.
Will CorneaGen IPO soon?
No public IPO plans have been announced for CorneaGen.
How can I track CorneaGen secondary market activity?
Caplight tracks bids, offers, and trades in CorneaGen's shares on secondary markets.